Since strong antibody responses are reliant on T cell help, the work presented in this paper set out to determine if patients who carry HLA types that allow a strong T cell response to PLP also allow elevated antibody responses to PLP, and to determine if there is any relationship between levels of anti-PLP antibodies and disease severity in MS. The gene discussed is PLP1; the disease is myeloid sarcoma.